Lymphangioleiomyomatosis

[1]  K. Ikeda,et al.  Lymphangioleiomyoma of the Uterus and Pelvic Lymph Nodes: A Report of 3 Cases, Including the Potentially Earliest Manifestation of Extrapulmonary Lymphangioleiomyomatosis. , 2020, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[2]  Weihong Zhang,et al.  Lymphangioleiomyomatosis , 2020, Seminars in Respiratory and Critical Care Medicine.

[3]  N. Gupta,et al.  Clinical outcomes and survival following lung transplantation in patients with lymphangioleiomyomatosis. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[4]  M. Kitaichi,et al.  Serum vascular endothelial growth factor-D as a diagnostic and therapeutic biomarker for lymphangioleiomyomatosis , 2019, PloS one.

[5]  E. Henske,et al.  Emerging biomarkers of lymphangioleiomyomatosis , 2018, Expert review of respiratory medicine.

[6]  J. Krischer,et al.  Efficacy and safety of sirolimus in lymphangioleiomyomatosis. , 2011, The New England journal of medicine.

[7]  W. Linehan,et al.  Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases. , 2010, Chest.

[8]  G. Amann,et al.  Recurrence of lymphangioleiomyomatosis after single lung transplantation: new insights into pathogenesis. , 2003, Human pathology.